Clinical Trials Logo

Filter by:
NCT ID: NCT04019808 Completed - Gastric Cancer Clinical Trials

Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population

LEGACY-3
Start date: July 30, 2019
Phase:
Study type: Observational

This study is divided into two parts: Part 1: An interventional study, with a pre-post study design to determinate the grade of knowledge of established GC risk factors. Part 2: An observational study to know impact on prevalence and infection eradication of H. pylori

NCT ID: NCT04018261 Completed - CMV Viremia Clinical Trials

Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients

Start date: July 4, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Marrow transplanted immunocompromised patients with cytomegalovirus (CMV) viral infection will be treated with CMV activated T-Lymphocytes. T-Lymphocytes will be obtained through an apheresis from a compatible donor. Safety and immunoreconstitution parameters in blood samples will be assessed up to +60 days after the treatment.

NCT ID: NCT04017325 Completed - Clinical trials for Cancer of the Prostate

European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up

Start date: March 17, 2016
Phase:
Study type: Observational

This is an open observational extended follow-up study of patients originally randomized into TOOKAD® Soluble VTP therapy or active surveillance (control group). Additional 60-month follow-up study

NCT ID: NCT04016337 Completed - Obesity Clinical Trials

Evaluation of New Beverages Rich in Bioactive Compounds for the Modulation of Energetic Metabolism in Overweight Adults

BEBESANO
Start date: September 1, 2017
Phase: N/A
Study type: Interventional

During last decades, an excessive intake of sugars has been observed in westernized countries, mainly due to the consumption of sugar-rich soft drinks. Epidemiological studies have pointed out a positive correlation between the consumption of such drinks and the risk of obesity, diabetes, and cardiovascular diseases. Therefore, there is a growing trend looking for new non-caloric alternatives (sweeteners) in order to reduce the sugar content of foodstuffs without losing their sweetness and tastefulness. However, some questions regarding sweeteners have recently arisen as their effects after long-term consumption have not been fully unravelled. They could also contribute to a higher caloric intake and to disrupt the gut microbiota. Besides seeking new alternatives for the high intake of sugar-rich drinks, there is a need for increasing the consumption of fruits and vegetables among general public. Developing new products to stretch the shelf-life of fresh fruits, preserving their nutrients, and reducing the energetic content of fruit juices should also be accomplished. In this sense, lemon juice has been proposed as an interesting ingredient in the elaboration of soft drinks due to its distinctive aroma and high nutritive value. Its combination with maqui berry juices contributes to stabilize the colour and phenolic compounds that both products contain (mainly flavanones for lemon juice and anthocyanins for maqui). The beneficial effects of these vegetal foodstuffs and their phenolic substances on glucose intolerance have been reported.The aim of BEBESANO is studying the beneficial effects of sugar-free, rich-in-phytochemicals drink consumption on postprandial hyperglycaemia, in order to provide alternatives to excessive sugar intake and counteract the postprandial response linked to sugar consumption in subjects with low levels of chronic inflammation such as overweight people. Moreover, BEBESANO will shed light on the interactions of food constituents with the main pathways involved in the lipid and glucose metabolism, oxidative stress, inflammation, and hormonal regulation in overweight population.

NCT ID: NCT04015466 Completed - Gastric Cancer Clinical Trials

Advanced GC Multi-omic Characterization in EU and CELAC Populations

LEGACY-2
Start date: June 12, 2019
Phase:
Study type: Observational

Observational study (cohort type) of advanced GC patients that will be recruited prospectively to study biological factors associated with the disease and relevant clinical outcomes.

NCT ID: NCT04014764 Completed - Multiple Myeloma Clinical Trials

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

(ANSWer)
Start date: December 15, 2019
Phase:
Study type: Observational [Patient Registry]

This is a prospective, multicenter observational study to collect clinically annotated biospecimens in order to assess the correlation between ex vivo data generated by the Notable assay platform and clinical outcome.

NCT ID: NCT04014075 Completed - Clinical trials for Adenocarcinoma - GEJ

DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02)

Start date: November 26, 2019
Phase: Phase 2
Study type: Interventional

This study will find out if trastuzumab deruxtecan is safe and works for participants with gastric or gastroesophageal junction cancer. They must have human epidermal growth factor receptor 2 (HER2)-positive gastric or gastro-esophageal junction (GEJ) cancer: - that cannot be removed surgically - that has moved to other parts of the body - that got worse during or after treatment that included trastuzumab The study will enroll about 80 participants. Sites will be in North America and the European Union.

NCT ID: NCT04012931 Completed - HIV Clinical Trials

A Study of Switching to RPV Plus Other ARVs in HIV-1-infected Children (Aged 2 to <12 Years) Who Are Virologically Suppressed

Start date: July 18, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the steady state pharmacokinetics (PK) of rilpivirine (RPV) and determine the appropriate dose of RPV in combination with other antiretrovirals (ARVs) in participants aged greater than or equal to 2 to less than 12 years and to evaluate the safety and tolerability of RPV in combination with other ARVs in participants of same age group over a 48-week treatment period with primary endpoint at Week 24.

NCT ID: NCT04012437 Completed - Clinical trials for Premature Ejaculation

Efficacy of App and Electronic Device in the Treatment of Premature Ejaculation

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

Randomized control trial to determine if we can produce increases in the IELT using a new masturbator electronic in subjects with premature ejaculation in combination with a exercise app, producing improvements in the quality and satisfaction of the sexuality of the patient.

NCT ID: NCT04012203 Completed - Healthy Clinical Trials

Multivariable Recovery After Exercise-induced Muscle Pain in the Forearm Muscles

Start date: February 4, 2019
Phase:
Study type: Observational [Patient Registry]

This study investigates the evolution of sensory, motor and tissue variables following exercise-induced pain in wrist extensor muscles in healthy subjects.